News

Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.
This article explores the complex interplay between drug addiction and HIV, highlighting how integrated harm reduction ...
Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.
University of Michigan researchers have uncovered new details of the process that HIV uses to hijack cells' transportation ...
The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...
The US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a ...
Eight million people living with HIV. Just over 6 million on treatment. Behind these big numbers lurk a universe of fascinating epidemiological dynamics. In this special briefing, Spotlight editor ...
Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though ...
These findings reveal a previously hidden layer of HIV-1's life cycle, shedding light on how the virus enhances its persistence, replication and ability to evade the immune system. They also point ...
That’s why scientists studying AIDS continue to search for weak spots in the virus’ infection cycle. HIV inserts its genes into the host ... By going back and forth between real-life results and the ...